Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Conditions

• Congenital Bleeding Disorder
• Haemophilia A

Interventions

• DRUG: turoctocog alfa

Sponsor

Novo Nordisk A/S